Novo Nordisk creates new unit to ramp up use of artificial intelligence and digital tools in research

Pharmaceutical firm Novo Nordisk is establishing a new, global focus area, bringing AI and other digital tools to its research and early development. In time, the unit will employ ”several hundreds of people,” says the head of the unit.
Lars Fogh Iversen will lead Novo Nordisk's new unit dubbed Digital Science & Innovation | Photo: Novo Nordisk / PR
Lars Fogh Iversen will lead Novo Nordisk's new unit dubbed Digital Science & Innovation | Photo: Novo Nordisk / PR
by CHRISTOPHER DUE KARLSSON, translated by daniel pedersen

Digital opportunities will soon be playing a more active role in the research conducted by Denmark’s biggest pharmaceutical firm, Novo Nordisk, which is why the company is establishing a new, global focus area for this purpose.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading